China Supply Pure Quality Erlotinib Hydrochloride CAS 183319-69-9

China Supply Pure Quality Erlotinib Hydrochloride CAS 183319-69-9


Product Name:Erlotinib hydrochloride
Synonyms:ERLOTINIB HCL;ERLOTINIB HCL SALT;ERLOTINIB HCL SALT :TARCEVA;Erlotinib, Hydrochloride Salt;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva;N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine;Tarceva HydrochlorideSee E625000
CAS:183319-69-9
MF:C22H24ClN3O4
MW:429.9
Product Categories:API;Molecular Targeted Antineoplastic;Heterocyclic Compounds;anti-neoplastic;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Tarceva;Antineoplastic;Anti-cancer&immunity;Inhibitors
Melting point:223-225°C
Indications and Usage:Erlotinib hydrochlorate is a small molecule tyrosine kinase inhibitor which acts reversibly on epidermal grow factor receptors, a hydrochloride of erlotinib, a molecular-targeted drug. The US Food and Drug Administration (FDA) has approved erlotinib (Tarceva) combined with gemcitabine as a first-line treatment for locally advanced and metastatic pancreatic cancer.
It is mainly used as a second- or third-line treatment for locally advanced or metstatic non-small cell lung cancer (NSCLC) and as a treatment for pancreatic cancer. It is used as a tyrosine inhibitor for NSCLC treatment.
Chemical Properties:Off-White Solid
Purity:99%
Package:1kg/25kg/package
Uses:Selective epidermal grow factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic
Uses:Erlotinib HCl is an HER1/EGFR inhibitor with IC50 of 2 nM.
Uses:Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Phase 3.
Erlotinib HCl is a small molecule inhibitor of epidermal grow factor receptor tyrosine kinase reversibility and is mainly used in the treatment of locally advanced or metastatic non-small cell lung cancer, second-line or third-line and in the treatment of pancreatic cancer .

 
Tianeptine sodium CAS  30123-17-2
Tianeptine sulfate CAS : 1224690-84-9
Tianeptine (Tianeptine Free Acid ) CAS : 66981-73-5
Paroxetine hydrochloride  CAS 78246-49-8
Levetiracetam  CAS : 102767-28-2
Parecoxib Sodium  CAS:198470-85-8
Atomoxetine Hydrochloride CAS 82248-59-7
Armodafinil CAS 112111-43-0
CDP-Choline Base CAS 987-78-0
Duloxetine HCl   CAS 136434-34-9
Fluoxetine Hydrochloride   CAS 56296-78-7
Phenibut  CAS 1078-21-3
Azaperone  CAS 1649-18-9
 
Pregabalin CAS 148553-50-8
Piracetam  CAS  7491-74-9
Aniracetam CAS : 72432-10-1 China Supply Pure Quality Erlotinib Hydrochloride CAS 183319-69-9


Product Name:Erlotinib hydrochloride
Synonyms:ERLOTINIB HCL;ERLOTINIB HCL SALT;ERLOTINIB HCL SALT :TARCEVA;Erlotinib, Hydrochloride Salt;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, Hydrochloride Salt, OSI 774, Tarceva;N-(3-Ethynylphenyl)-6,7-bis-(2-methoxyethoxy)-quinazolin-4-amine;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4yl]-(3-ethynyl-phenyl)-amine;Tarceva HydrochlorideSee E625000
CAS:183319-69-9
MF:C22H24ClN3O4
MW:429.9
Product Categories:API;Molecular Targeted Antineoplastic;Heterocyclic Compounds;anti-neoplastic;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Tarceva;Antineoplastic;Anti-cancer&immunity;Inhibitors
Melting point:223-225°C
Indications and Usage:Erlotinib hydrochlorate is a small molecule tyrosine kinase inhibitor which acts reversibly on epidermal grow factor receptors, a hydrochloride of erlotinib, a molecular-targeted drug. The US Food and Drug Administration (FDA) has approved erlotinib (Tarceva) combined with gemcitabine as a first-line treatment for locally advanced and metastatic pancreatic cancer.
It is mainly used as a second- or third-line treatment for locally advanced or metstatic non-small cell lung cancer (NSCLC) and as a treatment for pancreatic cancer. It is used as a tyrosine inhibitor for NSCLC treatment.
Chemical Properties:Off-White Solid
Purity:99%
Package:1kg/25kg/package
Uses:Selective epidermal grow factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic
Uses:Erlotinib HCl is an HER1/EGFR inhibitor with IC50 of 2 nM.
Uses:Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Phase 3.
Erlotinib HCl is a small molecule inhibitor of epidermal grow factor receptor tyrosine kinase reversibility and is mainly used in the treatment of locally advanced or metastatic non-small cell lung cancer, second-line or third-line and in the treatment of pancreatic cancer .

 
Tianeptine sodium CAS  30123-17-2
Tianeptine sulfate CAS : 1224690-84-9
Tianeptine (Tianeptine Free Acid ) CAS : 66981-73-5
Paroxetine hydrochloride  CAS 78246-49-8
Levetiracetam  CAS : 102767-28-2
Parecoxib Sodium  CAS:198470-85-8
Atomoxetine Hydrochloride CAS 82248-59-7
Armodafinil CAS 112111-43-0
CDP-Choline Base CAS 987-78-0
Duloxetine HCl   CAS 136434-34-9
Fluoxetine Hydrochloride   CAS 56296-78-7
Phenibut  CAS 1078-21-3
Azaperone  CAS 1649-18-9
 
Pregabalin CAS 148553-50-8
Piracetam  CAS  7491-74-9
Aniracetam CAS : 72432-10-1

Cosmetic Peptides

Pharmaceutical Intermediate,Ganirelix Acetate,Amino Acid

Cosmetic Peptides Co., Ltd. , http://www.ns-pharmaceuticals.com